<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>atezolizumab immunotherapy outcomes &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/atezolizumab-immunotherapy-outcomes/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 10:10:33 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>atezolizumab immunotherapy outcomes &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy</title>
		<link>https://bioengineer.org/innovative-urine-based-tumor-dna-test-promises-personalized-bladder-cancer-therapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 27 Jun 2025 18:18:49 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[atezolizumab immunotherapy outcomes]]></category>
		<category><![CDATA[BCG-unresponsive NMIBC]]></category>
		<category><![CDATA[Non-invasive cancer diagnostics]]></category>
		<category><![CDATA[personalized bladder cancer therapy]]></category>
		<category><![CDATA[urine tumor DNA analysis]]></category>
		<guid isPermaLink="false">https://bioengineer.org/innovative-urine-based-tumor-dna-test-promises-personalized-bladder-cancer-therapy/</guid>

					<description><![CDATA[A groundbreaking multi-institutional study has unveiled a promising approach to improving the management of bladder cancer by utilizing urine-based tumor DNA (utDNA) analysis. Published in the prestigious journal European Urology, the research highlights how quantifying utDNA can predict the risk of recurrence in patients undergoing immunotherapy, specifically those treated with atezolizumab. This advance heralds a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">250644</post-id>	</item>
	</channel>
</rss>
